Karyopharm Therapeutics' Grant

Karyopharm Therapeutics raised a round of funding on January 06, 2011. Investors include Multiple Myeloma Research Foundation.

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing small molecule modulators of nuclear transport. Karyopharm's selective inhibitors of nuclear export (SINE) function by tra…

Articles about Karyopharm Therapeutics' Grant: